IMMUNITYBIO, INC. Increase (Decrease) in Other Accounts Payable and Accrued Liabilities
IMMUNITYBIO, INC. (IBRX) reported Increase (Decrease) in Other Accounts Payable and Accrued Liabilities of $11.70 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities · last filed 2026-08-04
- IMMUNITYBIO, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2026-06-30 was $8.56M, a 1.83% decline year-over-year.
- IMMUNITYBIO, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2026-03-31 was $3.14M.
- IMMUNITYBIO, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2025-12-31 was $1.93M.
- IMMUNITYBIO, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2025-09-30 was $5.47M, a 12.16% decline year-over-year.
- IMMUNITYBIO, INC. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2025 was $3.18M.
- IMMUNITYBIO, INC. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2024 was -$1.51M, a 122.54% decline from fiscal 2023.
- IMMUNITYBIO, INC. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2023 was $6.69M, a 63.07% increase from fiscal 2022.
- IMMUNITYBIO, INC. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2022 was $4.10M, a 20.84% decline from fiscal 2021.
| Period end | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 3 month as first filed | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 6 month as first filed | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 9 month as first filed | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $8.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $11.70M 10-Q · filed 2026-08-04 | $13.63M derived: sum of 3 quarters · filed 2026-08-04 | $19.09M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | $3.14M 10-Q · filed 2026-05-07 | $5.06M derived: sum of 2 quarters · filed 2026-05-07 | $10.53M derived: sum of 3 quarters · filed 2026-05-07 | $19.25M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | $1.93M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $7.39M derived: sum of 2 quarters · filed 2026-02-23 | $16.12M derived: sum of 3 quarters · filed 2026-08-04 | $3.18M 10-K · filed 2026-02-23 | ||||
| 2025-09-30 | $5.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $14.19M derived: sum of 2 quarters · filed 2026-08-04 | $1.26M 10-Q · filed 2025-11-05 | -$855.00K derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | $8.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$4.21M 10-Q · filed 2026-08-04 | -$6.32M derived: sum of 3 quarters · filed 2026-08-04 | -$98.00K derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | -$12.93M 10-Q · filed 2026-05-07 | -$15.05M derived: sum of 2 quarters · filed 2026-05-07 | -$8.82M derived: sum of 3 quarters · filed 2026-05-07 | -$5.52M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | -$2.11M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $4.11M derived: sum of 2 quarters · filed 2026-02-23 | $7.41M derived: sum of 3 quarters · filed 2026-02-23 | -$1.51M 10-K · filed 2026-02-23 | ||||
| 2024-09-30 | $6.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $9.52M derived: sum of 2 quarters · filed 2025-11-05 | $606.00K 10-Q · filed 2025-11-05 | -$18.91M derived: sum of 4 quarters · filed 2026-02-23 | ||||
| 2024-06-30 | $3.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$5.62M 10-Q · filed 2025-08-05 | -$25.14M derived: sum of 3 quarters · filed 2026-02-23 | -$26.80M derived: sum of 4 quarters · filed 2026-02-23 | ||||
| 2024-03-31 | -$8.92M 10-Q · filed 2025-05-12 | -$28.43M derived: sum of 2 quarters · filed 2026-02-23 | -$30.09M derived: sum of 3 quarters · filed 2026-02-23 | -$20.82M derived: sum of 4 quarters · filed 2026-02-23 | ||||
| 2023-12-31 | -$19.52M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | -$21.18M derived: sum of 2 quarters · filed 2026-02-23 | -$11.90M derived: sum of 3 quarters · filed 2026-02-23 | $6.69M 10-K · filed 2026-02-23 | ||||
| 2023-09-30 | -$1.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $7.62M derived: sum of 2 quarters · filed 2024-11-12 | $26.20M 10-Q · filed 2024-11-12 | $23.05M derived: sum of 4 quarters · filed 2025-03-03 | ||||
| 2023-06-30 | $9.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $27.86M 10-Q · filed 2024-08-12 | $24.71M derived: sum of 3 quarters · filed 2025-03-03 | $31.36M derived: sum of 4 quarters · filed 2025-03-03 | ||||
| 2023-03-31 | $18.59M 10-Q · filed 2024-05-09 | $15.44M derived: sum of 2 quarters · filed 2025-03-03 | $22.09M derived: sum of 3 quarters · filed 2025-03-03 | $11.80M derived: sum of 4 quarters · filed 2025-03-03 | ||||
| 2022-12-31 | -$3.15M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $3.50M derived: sum of 2 quarters · filed 2025-03-03 | -$6.79M derived: sum of 3 quarters · filed 2025-03-03 | $4.10M 10-K · filed 2025-03-03 | ||||
| 2022-09-30 | $6.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$3.64M derived: sum of 2 quarters · filed 2023-11-09 | $7.25M 10-Q · filed 2023-11-09 | $11.81M derived: sum of 4 quarters · filed 2024-03-19 | ||||
| 2022-06-30 | -$10.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $602.00K 10-Q · filed 2023-08-08 | $5.16M derived: sum of 3 quarters · filed 2024-03-19 | $9.61M derived: sum of 4 quarters · filed 2024-03-19 | ||||
| 2022-03-31 | $10.89M 10-Q · filed 2023-05-11 | $15.45M derived: sum of 2 quarters · filed 2024-03-19 | $19.89M derived: sum of 3 quarters · filed 2024-03-19 | $17.97M derived: sum of 4 quarters · filed 2024-03-19 | ||||
| 2021-12-31 | $4.56M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $9.00M derived: sum of 2 quarters · filed 2024-03-19 | $7.08M derived: sum of 3 quarters · filed 2024-03-19 | $5.18M 10-K · filed 2024-03-19 | ||||
| 2021-09-30 | $4.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $2.52M derived: sum of 2 quarters · filed 2022-11-09 | $624.00K 10-Q · filed 2022-11-09 | $1.96M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2021-06-30 | -$1.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$3.82M 10-Q · filed 2022-08-08 | -$2.48M derived: sum of 3 quarters · filed 2023-03-01 | -$1.54M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2021-03-31 | -$1.89M 10-Q · filed 2022-05-10 | -$556.00K derived: sum of 2 quarters · filed 2023-03-01 | $386.00K derived: sum of 3 quarters · filed 2023-03-01 | $2.37M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2020-12-31 | $1.34M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $2.28M derived: sum of 2 quarters · filed 2023-03-01 | $4.27M derived: sum of 3 quarters · filed 2023-03-01 | $12.49M 10-K · filed 2023-03-01 | $3.69M 10-K · filed 2021-03-04 | |||
| 2020-09-30 | $942.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $2.93M derived: sum of 2 quarters · filed 2021-11-12 | $11.16M 10-Q · filed 2021-11-12 | $1.57M 10-Q · filed 2020-11-09 | $10.98M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2020-06-30 | $1.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $10.22M 10-Q · filed 2021-08-12 | $1.47M 10-Q · filed 2020-08-07 | $10.04M derived: sum of 3 quarters · filed 2022-03-01 | $10.88M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2020-03-31 | $8.23M 10-Q · filed 2021-05-14 | $997.00K 10-Q · filed 2020-05-11 | $8.05M derived: sum of 2 quarters · filed 2022-03-01 | $8.90M derived: sum of 3 quarters · filed 2022-03-01 | -$4.37M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2019-12-31 | -$174.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $669.00K derived: sum of 2 quarters · filed 2022-03-01 | -$12.59M derived: sum of 3 quarters · filed 2022-03-01 | -$11.80M 10-K · filed 2022-03-01 | -$12.02M 10-K · filed 2020-03-25 | |||
| 2019-09-30 | $843.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$12.42M derived: sum of 2 quarters · filed 2020-11-09 | -$11.62M 10-Q · filed 2020-11-09 | -$13.53M derived: sum of 4 quarters · filed 2021-03-04 | ||||
| 2019-06-30 | -$13.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | -$12.46M 10-Q · filed 2020-08-07 | -$14.38M derived: sum of 3 quarters · filed 2021-03-04 | -$360.00K derived: sum of 4 quarters · filed 2021-03-04 | ||||
| 2019-03-31 | $797.00K 10-Q · filed 2020-05-11 | -$1.11M derived: sum of 2 quarters · filed 2021-03-04 | $12.90M derived: sum of 3 quarters · filed 2021-03-04 | $11.63M derived: sum of 4 quarters · filed 2021-03-04 | ||||
| 2018-12-31 | -$1.91M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $12.11M derived: sum of 2 quarters · filed 2021-03-04 | $10.83M derived: sum of 3 quarters · filed 2021-03-04 | $12.71M 10-K · filed 2021-03-04 | ||||
| 2018-09-30 | $14.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $12.74M derived: sum of 2 quarters · filed 2018-11-07 | $14.62M 10-Q · filed 2018-11-07 | $14.77M derived: sum of 4 quarters · filed 2020-03-25 | ||||
| 2018-06-30 | -$1.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | $603.00K 10-Q · filed 2018-08-06 | $750.00K derived: sum of 3 quarters · filed 2020-03-25 | $1.41M derived: sum of 4 quarters · filed 2020-03-25 | ||||
| 2018-03-31 | $1.88M 10-Q · filed 2019-05-08 | $2.02M derived: sum of 2 quarters · filed 2020-03-25 | $2.68M derived: sum of 3 quarters · filed 2020-03-25 | $1.15M derived: sum of 4 quarters · filed 2020-03-25 | ||||
| 2017-12-31 | $147.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | $805.00K derived: sum of 2 quarters · filed 2020-03-25 | -$733.00K derived: sum of 3 quarters · filed 2020-03-25 | -$299.00K 10-K · filed 2020-03-25 | ||||
| 2017-09-30 | $658.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$880.00K derived: sum of 2 quarters · filed 2018-11-07 | -$446.00K 10-Q · filed 2018-11-07 | -$773.00K derived: sum of 4 quarters · filed 2019-03-13 | ||||
| 2017-06-30 | -$1.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | -$1.10M 10-Q · filed 2018-08-06 | -$1.43M derived: sum of 3 quarters · filed 2019-03-13 | -$615.00K derived: sum of 4 quarters · filed 2019-03-13 | ||||
| 2017-03-31 | $434.00K 10-Q · filed 2018-05-07 | $107.00K derived: sum of 2 quarters · filed 2019-03-13 | $923.00K derived: sum of 3 quarters · filed 2019-03-13 | $1.32M derived: sum of 4 quarters · filed 2019-03-13 | ||||
| 2016-12-31 | -$327.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $489.00K derived: sum of 2 quarters · filed 2019-03-13 | $891.00K derived: sum of 3 quarters · filed 2019-03-13 | $2.13M 10-K · filed 2019-03-13 | ||||
| 2016-09-30 | $816.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $1.22M derived: sum of 2 quarters · filed 2017-11-07 | $2.45M 10-Q · filed 2017-11-07 | $3.46M derived: sum of 4 quarters · filed 2018-03-12 | ||||
| 2016-06-30 | $402.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $1.64M 10-Q · filed 2017-08-07 | $2.65M derived: sum of 3 quarters · filed 2018-03-12 | $1.32M derived: sum of 4 quarters · filed 2018-03-12 | ||||
| 2016-03-31 | $1.24M 10-Q · filed 2017-05-08 | $2.24M derived: sum of 2 quarters · filed 2018-03-12 | $915.00K derived: sum of 3 quarters · filed 2018-03-12 | $3.23M derived: sum of 4 quarters · filed 2018-03-12 | ||||
| 2015-12-31 | $1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | -$321.00K derived: sum of 2 quarters · filed 2018-03-12 | $1.99M derived: sum of 3 quarters · filed 2018-03-12 | $1.99M 10-K · filed 2018-03-12 | ||||
| 2015-09-30 | -$1.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $987.00K derived: sum of 2 quarters · filed 2016-11-10 | $984.00K 10-Q · filed 2016-11-10 | |||||
| 2015-06-30 | $2.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $2.31M 10-Q · filed 2016-08-15 | ||||||
| 2015-03-31 | -$3.00K 10-Q · filed 2016-05-16 | |||||||
| 2014-12-31 | -$314.00K 10-K · filed 2017-03-15 | |||||||
| 2013-12-31 | $309.00K 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |